Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient
Philipp Jent(University of Bern), Charles Béguelin(University of Bern), Hansjakob Furrer(University of Bern), Sabina Berezowska(University Hospital of Lausanne), Mafalda Trippel(University of Bern), Alexander Pöllinger(University of Bern), Rupert Langer(Johannes Kepler University of Linz), Manuel Frey(University of Bern)
Cited by 8
Related Papers
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
|British Journal of Cancer|2010|301